Patents by Inventor Eddine Saiah

Eddine Saiah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytokine inhibitors
    Publication number: 20050107399
    Abstract: The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.
    Type: Application
    Filed: September 10, 2004
    Publication date: May 19, 2005
    Inventors: Erik Boman, Susana Ceide, Russell Dahl, Nancy Delaet, Justin Ernst, Antonio Montalban, Jeffrey Kahl, Christopher Larson, Stephen Miller, Hiroshi Nakanishi, Edward Roberts, Eddine Saiah, Robert Sullivan, Zhijun Wang
  • Compounds for the treatment of HIV infection
    Publication number: 20040248850
    Abstract: The present invention is related to compounds, their intermediates, processes for their preparation and use, and pharmaceutical compositions comprising the compounds. The novel compounds are useful in therapy, and in particular for the treatment of viral infection, particularly HIV infection.
    Type: Application
    Filed: February 6, 2004
    Publication date: December 9, 2004
    Applicant: Kemia, Inc.
    Inventors: Justin T. Ernst, Erik Boman, Susana C. Ceide, Antonio G. Montalban, Hiroshi Nakanishi, Edward Roberts, Eddine Saiah, Christopher Lum
  • Tetrahydroquinoline derivatives as antithrombotic agents
    Patent number: 6825208
    Abstract: This invention relates generally to tetracyclic tetrahydroquinoline compounds, and analogues thereof, and pharmaceutically acceptable salt forms thereof, which are selective inhibitors of serine protease enzymes, especially factor VIIa; pharmaceutical compositions containing the same; and methods of using the same as anticoagulant agents for modulation of the coagulation cascade.
    Type: Grant
    Filed: August 20, 2002
    Date of Patent: November 30, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Jinglan Zhou, Leslie Robinson, Nikolaus M. Gubernator, Eddine Saiah, Xu Bai, Xin Gu
  • Tetrahydroquinoline derivatives as antithrombotic agents
    Publication number: 20030225110
    Abstract: This invention relates generally to tetracyclic tetrahydroquinoline compounds, and analogues thereof, and pharmaceutically acceptable salt forms thereof, which are selective inhibitors of serine protease enzymes, especially factor VIIa; pharmaceutical compositions containing the same; and methods of using the same as anticoagulant agents for modulation of the coagulation cascade.
    Type: Application
    Filed: August 20, 2002
    Publication date: December 4, 2003
    Inventors: Jinglan Zhou, Leslie Robinson, Nikolaus M. Gubernator, Eddine Saiah, Xu Bai, Xin Gu